No Data
Oncolys BioPharma: Earnings Conference materials
Oncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio
Oncolys BioPharma: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Oncolys BioPharma: Notice regarding differences between full-year results and previous fiscal year results
Oncolys BioPharma FY Parent Loss Y1.68B Vs Loss Y1.94B
Daifuku construction, KFC, Duskin, and Shin Nihon Seiyaku (7th) (1332-5976)
※ The above Calendar is only a plan and may be subject to change due to company circumstances. --------------------------------------- February 7 (Friday) <1332> Nissui <1429> Aqua Japan <143A> Ishin <1450> Tanaka Construction Industry <151A> Dai <167A> Ryosan Ryoho <1717> Meihou Facility <1721> Comsys